Jun 16, 2026 07:05AM
Jun 15, 2026 04:34PM
Jun 15, 2026 04:34PM
Jun 8, 2026 04:35PM
Jun 8, 2026 04:35PM
Jun 8, 2026 04:30PM
Jun 8, 2026 04:30PM Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study
Jun 4, 2026 04:15PM
Jun 4, 2026 04:15PM
Jun 2, 2026 08:30AM
Jun 2, 2026 08:30AM
May 27, 2026 02:00AM
May 27, 2026 02:00AM
May 22, 2026 02:00PM FDA approves Gilead's Hepcludex as first HDV treatment in U.S.
May 22, 2026 02:00PM
May 22, 2026 01:42PM
May 22, 2026 07:47AM
May 22, 2026 07:47AM
May 21, 2026 05:00PM
May 13, 2026 08:30AM
May 13, 2026 08:30AM Gilead to Present New Data Advancing Care in PBC and Viral Hepatitis at EASL 2026
May 7, 2026 04:01PM
Apr 29, 2026 08:30AM
Apr 29, 2026 08:30AM
Apr 28, 2026 08:45AM
Apr 28, 2026 08:45AM
Apr 14, 2026 12:03PM
Apr 14, 2026 12:00PM PEPFAR and The Global Fund Make Additional Investment in Gilead’s Lenacapavir for HIV Prevention to Further Expand Access
Mar 31, 2026 06:19AM
Mar 24, 2026 06:36AM
Mar 23, 2026 06:15PM
Mar 23, 2026 06:15PM
Feb 25, 2026 01:50PM
Feb 25, 2026 01:44PM
Feb 25, 2026 10:02AM UBS Reiterates Buy Rating on Gilead Sciences (GILD) Following ACLX Acquisition Announcement
Feb 24, 2026 08:23AM
Feb 23, 2026 12:32PM
Feb 23, 2026 08:09AM
Feb 23, 2026 06:01AM
Feb 23, 2026 06:01AM
Feb 17, 2026 08:30AM
Feb 10, 2026 04:01PM Gilead Sciences Announces Fourth Quarter and Full Year 2025 Financial Results
Feb 6, 2026 08:30AM
Feb 6, 2026 08:30AM
Jan 30, 2026 06:28AM
Jan 27, 2026 08:24AM
Jan 21, 2026 05:00PM
Jan 21, 2026 05:00PM
Dec 15, 2025 08:30AM Gilead HIV drug combination meets primary goal in phase 3 trial
Dec 15, 2025 08:30AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All